Article | July 25, 2023

FDA's Proposed Compliance "Revamp": What Does It Mean for the Agency, Industry, and Consumers?

Read More

Article | July 20, 2023

State Registration Enforcement

Read More

Article | July 17, 2023

FDA Publishes First Draft Guidance for Clinical Trials with Psychedelic Drugs

Read More

Article | June 27, 2023

Getting What You Paid For: Acquisition Claims Considerations

Read More

Article | June 21, 2023

Beyond Paperwork: Assessing the Effectiveness of a Compliance Program

Read More

Article | June 14, 2023

New WA Privacy Law ‘Turns The Beat Around’ on Drug and Device Makers

Read More

Article | June 05, 2023

Whose Data Breach Is It Anyway?

Read More

Article | May 31, 2023

Healthcare Enforcement in a Post-Pandemic World

Read More

Article | April 28, 2023

Exciting News and Updates at Gardner Law

Read More

Article | April 27, 2023

REMINDER: Nevada Certification Submission Deadline is June 1

Read More

Article | March 29, 2023

The Evolving FDA Regulatory Landscape of Artificial Intelligence

Read More

Article | February 23, 2023

REMINDER: Sunshine Act reporting deadline is March 31, 2023

Read More

Article | February 14, 2023

Medical Device Cybersecurity: Are you Prepared?

Read More

Article | January 24, 2023

FDA Violations and the Park Doctrine Threat

Read More

Article | December 19, 2022

The Buzz on Med Device Cybersecurity

Read More

Article | October 20, 2022

What’s On the Radar of In-House Attorneys?

Read More

Article | September 26, 2022

Anti-Fraud & Sunshine Update

Read More

Article | September 14, 2022

Do you know when to report a medical device complaint?

Read More

Article | September 06, 2022

2022 Privacy Update

Read More

Article | August 23, 2022

Are you Ready for Inspection? Best Practices to “Survive” FDA Inspections

Read More

Article | August 16, 2022

FDA’s New Draft Guidance on Cybersecurity

Read More

Article | August 08, 2022

Are you Submission Ready? FDA Medical Device Submission Tips & Tricks

Read More

Article | July 27, 2022

Clinical Research: Hot Topics and Best Practices

Read More

Article | July 11, 2022

Back on the Case: FDA Issues Fresh Enforcement Letters

Read More